Cipher Pharmaceuticals Inc  

(Public, TSE:CPH)   Watch this stock  
Find more results for TSE:DND
7.32
-0.08 (-1.08%)
Aug 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 7.22 - 7.93
52 week 7.02 - 19.52
Open 7.44
Vol / Avg. 72,844.00/76,095.00
Mkt cap 189.47M
P/E 11.14
Div/yield     -
EPS 0.66
Shares 25.96M
Beta -0.29
Inst. own     -
Sep 10, 2015
Cipher Pharmaceuticals Inc at Rodman & Renshaw Global Investment Conference - 9:10AM EDT - Add to calendar
Aug 14, 2015
Q2 2015 Cipher Pharmaceuticals Inc Earnings Call
Aug 14, 2015
Q2 2015 Cipher Pharmaceuticals Inc Earnings Release
Aug 12, 2015
Cipher Pharmaceuticals Inc at Canaccord Genuity Growth Conference
Jun 2, 2015
Cipher Pharmaceuticals Inc at Jefferies Global Healthcare Conference
  

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -6.32% 63.96%
Operating margin 3.17% 61.27%
EBITD margin - 67.80%
Return on average assets -2.63% 31.61%
Return on average equity -4.23% 41.33%
Employees 13 -
CDP Score - -

Address

2345 Argentia Road, Suite 100A
MISSISSAUGA, ON L5N 8K4
Canada
+1-905-6025840 (Phone)
+1-905-6020628 (Fax)

Website links

Description

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on dermatology. The Company acquires products that fulfill medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. The Company's dermatology products include Sitavig, Absorica, Epuris, Beteflam, Dermadexin, Pruridexin, Ozenoxacin, CF101, ASF-1096 and Nanolipolee-007. The Company's other products include Lipofen, Conzip and Durela.

Officers and directors

Gerald P. McDole Independent Chairman of the Board
Age: 75
Shawn Patrick O'Brien President, Chief Executive Officer
Norman C. Evans Chief Financial Officer, Secretary
Age: 60
Joan Chypyha President, General Manager - Canada
Joseph Pecora President and General Manager - USA
Lorne Markowitz Vice President of Sales and Marketing
Linda Melanie Angaritis Vice President - Global Regulatory Compliance and Quality
Louise Blythe Vice President - Regulatory Affairs
Lynne Bulger Vice President - Medical and Clinical Affairs
Brian Rosenberger Vice President - Alliance and Strategic Portfolio Management